Davide Leone & Partners Investment CO Ltd. Iovance Biotherapeutics, Inc. Transaction History

Davide Leone & Partners Investment CO Ltd.

$22.9 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $869,850 - $1.76 Million	-53,267 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $532,745 - $977,227	18,582 Added 53.57%	53,267 $1.69 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $972,567 - $1.74 Million	34,685 New	34,685 $1.61 Million

Others Institutions Holding IOVA

# of Institutions

320

Shares Held

238M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Account